PBH Prestige Consumer Healthcare Inc.

49.60USD-2.02%Mkt Cap: 2.35B USDP/E: 15.31

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and interna…

Institutional holders20 on file

Key Statistics

Company
Market Cap2.35B USD
Enterprise Value4.48B USD
Revenue (TTM)1.17B USD
Gross Profit595.58M USD
Net Income (TTM)190.30M USD
Revenue/Share24.53 USD
Last Price49.60 USD
Fiscal Year EndMar 2026
MR QuarterSep 2026
Employees890
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)15.31
P/E (Forward)9.75
PEG1.44
EV/EBITDA12.98
EV/Revenue3.84
P/S2.01
P/B1.21
EPS (TTM)3.24 USD
EPS (Forward)5.08 USD
52W Range
41.7727% of range71.07
52W High71.07 USD
52W Low41.77 USD
Profitability
Gross Margin54.71%
Oper. Margin26.43%
EBITDA Margin29.57%
Profit Margin17.48%
ROE10.08%
ROA5.45%
ROIC7.97%
ROCE9.17%
Growth
Revenue Growth22.70%
Earnings Growth-38.40%
Cash Flow & Leverage
Operating CF257.63M USD
CapEx (TTM)11.18M USD
FCF Margin12.64%
FCF Yield6.28%
Net Debt2.08B USD
Net Debt/EBITDA6.03
Net Debt/FCF14.10
Balance Sheet
Debt/Equity0.55
Current Ratio2.92
Quick Ratio1.73
Book Value/Sh41.03 USD
Cash/Share0.98 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.6 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)66.20 USD
Upside (mean)+33.5%
Target Range51.00 USD – 75.00 USD
51.00+33.5% to mean75.00
# Analysts5
Ownership
Shares Out.47.40M
Float46.72M
Insiders1.41%
Institutions118.51%
Short Interest
Short Ratio7.9d
Short % Float10.80%
Short % Out.8.95%
Shares Short4.24M
Short (prev mo.)4.64M
Technical
SMA 5047.32 (+4.8%)
SMA 20053.06 (-6.5%)
Beta0.29
S&P 52W Chg12.08%
Avg Vol (30d)591.35K
Avg Vol (10d)738.97K
Technical Indicators
RSI (14)55.7
MACD0.0741
MACD Signal-0.3337
MACD Hist.+0.4078
BB Upper52.73 USD
BB Middle47.48 USD
BB Lower42.22 USD
BB Width22.14%
ATR (14)2.022 USD
Vol Ratio (20d)0.80x

About Prestige Consumer Healthcare (NYSE: PBH)

›

Prestige Consumer Healthcare (NYSE: PBH) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector, and reports about 890 employees.

The shares were at 49.60 USD on 19 November 2026, down 17.3% over 52 weeks. Its 52-week range is 41.77 USD to 71.07 USD: the price is 30.2% below the high and 18.7% above the low.

At a market capitalisation of 2.35B USD, it trades at 15.3 times trailing earnings and 9.8 times forward earnings. The median trailing P/E of its 17 largest Drug Manufacturers - Specialty & Generic peers is 24.7, a discount of 38% for PBH.

Prestige Consumer Healthcare reports return on equity of 10.1%, an operating margin of 26.4% and revenue up 22.7% year over year.

Its debt exceeds its cash by 2.08B USD, a debt-to-equity ratio of 0.55. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 5 analysts cover the stock, with an average rating of Buy; their mean price target of 66.20 USD is 33.5% above the current price. The next earnings report is expected on 4 February 2027.